Lifordi Immunotherapeutics, Inc., a biotech company developing antibody-drug conjugates (ADCs) for the treatment of ...

Scientists at La Jolla Institute for Immunology (LJI) have discovered how a mutated gene kicks off a dangerous chain of ...

Scientists at La Jolla Institute for Immunology (LJI) have discovered how a mutated gene kicks off a dangerous chain of ...

EBBH-2024 is under clinical development by Essen Biotech and currently in Phase II for Diffuse Large B-Cell Lymphoma.

Tonsil cancer is a type of head and neck cancer. Head and neck cancers include cancers of the tongue; the back of the tongue, ...

Alecsat is under clinical development by CytoVac and currently in Phase II for Triple-Negative Breast Cancer (TNBC).

The protease mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) is a signaling protein with both molecular ...

By inhibiting the DNA polymerases, BKC enhances the endogenous RS in cancer cells, leading to increased DNA damage. IBC specifically inhibits CHK2 to prevent DNA repair. The combined use of BKC and ...

INR:6312. football betting tips Novartis reaches hundreds of millions of dollars collaboration to develop novel TCR cell therapy Chia Tai Qingjiang's anti-i ...

Malignancies of lymphoid cells range from the most indolent to the most aggressive human malignancies and often compromise ...

Assad, is reportedly battling acute myeloid leukaemia, an aggressive cancer of the bone marrow and the blood. The former ...

B-cell lymphoma is a type of blood cancer that affects the B lymphocytes of the immune system. They usually arise in the lymph nodes or in other lymphoid tissue, such as the spleen, bone marrow ...